Raymond Dwek's most recent trade in United Therapeutics Corp was a trade of 3,650 Stock Options done . Disclosure was reported to the exchange on July 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Raymond Dwek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 3,650 | 3,650 | - | - | Stock Options | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 21 Apr 2025 | 3,000 | 4,750 (0%) | 0% | 175.4 | 526,290 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2025 | 3,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 285.57 per share. | 21 Apr 2025 | 3,000 | 1,750 (0%) | 0% | 285.6 | 856,710 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 285.16 per share. | 14 Apr 2025 | 3,000 | 1,750 (0%) | 0% | 285.2 | 855,480 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 14 Apr 2025 | 3,000 | 4,750 (0%) | 0% | 175.4 | 526,290 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 3,000 | 3,000 | - | - | Stock Option | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 07 Apr 2025 | 4,000 | 5,750 (0%) | 0% | 175.4 | 701,720 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 284.55 per share. | 07 Apr 2025 | 4,000 | 1,750 (0%) | 0% | 284.6 | 1,138,200 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 4,000 | 6,000 | - | - | Stock Option | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 5,000 | 10,000 | - | - | Stock Options | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 02 Aug 2024 | 5,000 | 6,750 (0%) | 0% | 175.4 | 877,150 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 327.96 per share. | 02 Aug 2024 | 1,300 | 2,750 (0%) | 0% | 328.0 | 426,342 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 320.39 per share. | 02 Aug 2024 | 900 | 5,850 (0%) | 0% | 320.4 | 288,349 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 321.29 per share. | 02 Aug 2024 | 900 | 4,950 (0%) | 0% | 321.3 | 289,158 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 326.40 per share. | 02 Aug 2024 | 900 | 4,050 (0%) | 0% | 326.4 | 293,757 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 328.99 per share. | 02 Aug 2024 | 900 | 1,850 (0%) | 0% | 329.0 | 296,089 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 330.39 per share. | 02 Aug 2024 | 100 | 1,750 (0%) | 0% | 330.4 | 33,039 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,890 | 2,890 | - | - | Stock Options | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 22 Apr 2024 | 3,000 | 4,750 (0%) | 0% | 88.0 | 264,090 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 234.06 per share. | 22 Apr 2024 | 3,000 | 1,750 (0%) | 0% | 234.1 | 702,180 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2024 | 3,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 235.08 per share. | 15 Apr 2024 | 3,000 | 1,750 (0%) | 0% | 235.1 | 705,240 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 15 Apr 2024 | 3,000 | 4,750 (0%) | 0% | 88.0 | 264,090 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 3,000 | 3,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 08 Apr 2024 | 4,000 | 5,750 (0%) | 0% | 88.0 | 352,120 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 236.96 per share. | 08 Apr 2024 | 4,000 | 1,750 (0%) | 0% | 237.0 | 947,840 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 4,000 | 6,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 4,560 | 4,560 | - | - | Stock Options | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 1,750 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 1,750 | 1,750 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 230.76 per share. | 21 Apr 2023 | 2,000 | 0 (0%) | 0% | 230.8 | 461,520 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 2,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 21 Apr 2023 | 2,000 | 2,000 (0%) | 0% | 63.9 | 127,800 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 14 Apr 2023 | 2,000 | 2,000 (0%) | 0% | 63.9 | 127,800 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2023 | 2,000 | 2,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 228.72 per share. | 14 Apr 2023 | 2,000 | 0 (0%) | 0% | 228.7 | 457,440 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 10 Apr 2023 | 3,000 | 3,000 (0%) | 0% | 63.9 | 191,700 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 223.07 per share. | 10 Apr 2023 | 3,000 | 0 (0%) | 0% | 223.1 | 669,210 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2023 | 3,000 | 4,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 5,000 | 10,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 266.80 per share. | 07 Nov 2022 | 5,000 | 0 (0%) | 0% | 266.8 | 1,334,000 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 07 Nov 2022 | 5,000 | 5,000 (0%) | 0% | 88.0 | 440,150 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 223.48 per share. | 09 Sep 2022 | 3,000 | 0 (0%) | 0% | 223.5 | 670,440 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2022 | 3,000 | 7,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 09 Sep 2022 | 3,000 | 3,000 (0%) | 0% | 63.9 | 191,700 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 2,160 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 241.29 per share. | 07 Jul 2022 | 2,160 | 0 (0%) | 0% | 241.3 | 521,186 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 2,160 | 2,160 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Raymond Dwek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 1,750 | 1,750 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 26 May 2022 | 5,000 | 7,000 (0%) | 0% | 63.9 | 319,500 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 224.78 per share. | 26 May 2022 | 5,000 | 2,000 (0%) | 0% | 224.8 | 1,123,900 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 5,000 | 10,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 05 May 2022 | 2,000 | 2,000 (0%) | 0% | 48.1 | 96,220 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2022 | 2,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 186.99 per share. | 05 May 2022 | 2,000 | 0 (0%) | 0% | 187.0 | 373,980 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 179.34 per share. | 28 Apr 2022 | 2,000 | 0 (0%) | 0% | 179.3 | 358,680 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 2,000 | 2,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 28 Apr 2022 | 2,000 | 2,000 (0%) | 0% | 48.1 | 96,220 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 21 Apr 2022 | 2,000 | 2,000 (0%) | 0% | 48.1 | 96,220 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 2,000 | 4,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 190.22 per share. | 21 Apr 2022 | 2,000 | 0 (0%) | 0% | 190.2 | 380,440 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2022 | 2,000 | 6,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 191.91 per share. | 14 Apr 2022 | 2,000 | 0 (0%) | 0% | 191.9 | 383,820 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 14 Apr 2022 | 2,000 | 2,000 (0%) | 0% | 48.1 | 96,220 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2022 | 2,000 | 8,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 190.11 per share. | 07 Apr 2022 | 2,000 | 0 (0%) | 0% | 190.1 | 380,220 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 07 Apr 2022 | 2,000 | 2,000 (0%) | 0% | 48.1 | 96,220 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 202.09 per share. | 08 Nov 2021 | 3,000 | 0 (0%) | 0% | 202.1 | 606,270 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2021 | 3,000 | 10,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 08 Nov 2021 | 3,000 | 3,000 (0%) | 0% | 48.1 | 144,330 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 2,160 | 2,160 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale of securities on an exchange or to another person at price $ 176.01 per share. | 29 Jun 2021 | 3,360 | 0 (0%) | 0% | 176.0 | 591,394 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 3,360 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 3,360 | 3,360 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 198.14 per share. | 05 May 2021 | 2,000 | 0 (0%) | 0% | 198.1 | 396,280 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 2,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 05 May 2021 | 2,000 | 2,000 (0%) | 0% | 54.8 | 109,540 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 205.62 per share. | 28 Apr 2021 | 2,000 | 0 (0%) | 0% | 205.6 | 411,240 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2021 | 2,000 | 2,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 28 Apr 2021 | 2,000 | 2,000 (0%) | 0% | 54.8 | 109,540 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 211.93 per share. | 21 Apr 2021 | 2,000 | 0 (0%) | 0% | 211.9 | 423,860 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 2,000 | 4,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 21 Apr 2021 | 2,000 | 2,000 (0%) | 0% | 54.8 | 109,540 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 202.78 per share. | 14 Apr 2021 | 2,000 | 0 (0%) | 0% | 202.8 | 405,560 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2021 | 2,000 | 6,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 14 Apr 2021 | 2,000 | 2,000 (0%) | 0% | 54.8 | 109,540 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2021 | 2,000 | 8,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 07 Apr 2021 | 2,000 | 2,000 (0%) | 0% | 54.8 | 109,540 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 191.10 per share. | 07 Apr 2021 | 2,000 | 0 (0%) | 0% | 191.1 | 382,200 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 139.28 per share. | 10 Nov 2020 | 2,000 | 0 (0%) | 0% | 139.3 | 278,560 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 10 Nov 2020 | 2,000 | 2,000 (0%) | 0% | 48.1 | 96,220 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 2,000 | 13,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 5,000 | 10,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond Dwek | Director | Sale or transfer of securities back to the company at price $ 133.98 per share. | 02 Nov 2020 | 5,000 | 0 (0%) | 0% | 134.0 | 669,900 | Common Stock |
| United Therapeutics Corp | Raymond Dwek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 02 Nov 2020 | 5,000 | 5,000 (0%) | 0% | 54.8 | 273,850 | Common Stock |